A Year Of Change: Sandoz Completes A Transformational 2023

Spinoff From Novartis Caps A Year That Also Saw Plenty Of Deals And Launches

Paper aeroplane spin
For Sandoz, much revolved around the spinoff from Novartis in 2023 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business